Register entry
Knoa Pharma LLC
- Registered sites
- 1
- Drug products
- 20
- Live patents
- 309
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Finished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Knoa Pharmaceuticals LLC | Wilson, NCUnited States | Finished drug manufacture | 3002960808 |
Exclusivity
Patents
309Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | Oct 2035 |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | Nov 2038 |
| HYSINGLA ER | HYDROCODONE BITARTRATE | Aug 2027 |
| HYSINGLA ER | HYDROCODONE BITARTRATE | Dec 2031 |
| OXYCONTIN | OXYCODONE HYDROCHLORIDE | Aug 2027 |
| OXYCONTIN | OXYCODONE HYDROCHLORIDE | Mar 2030 |
| ZURNAI (AUTOINJECTOR) | NALMEFENE HYDROCHLORIDE | Nov 2039 |
Catalogue
Marketed products
20Showing 20 of 20.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Butrans | buprenorphine | PATCH, EXTENDED RELEASE | NDA |
| Butrans | buprenorphine | PATCH, EXTENDED RELEASE | NDA |
| Butrans | buprenorphine | PATCH, EXTENDED RELEASE | NDA |
| Butrans | buprenorphine | PATCH, EXTENDED RELEASE | NDA |
| Butrans | buprenorphine | PATCH, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| Hysingla ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE | NDA |
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | INJECTION, SOLUTION | ANDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| OxyContin | oxycodone hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| Zurnai | NALMEFENE HYDROCHLORIDE | INJECTION, SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.